Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

S. Loi, S. Michiels, R. Salgado, N. Sirtaine, V. Jose, D. Fumagalli, P.-L. Kellokumpu-Lehtinen, P. Bono, V. Kataja, C. Desmedt, M.J. Piccart, S. Loibl, C. Denkert, M.J. Smyth, H. Joensuu, C. Sotiriou

Journal: Annals of Oncology

Publisher: Elsevier BV

Citations are the number of DOI-registered works in Crossref that cite this paper; references are how many works it cites. Full text is on the publisher site via the DOI link.